Fundz

Allos AI raises $5M in seed funding led by Oxford Science Enterprises to commercialize its glass-box Causal AI platform for drug reformulation.

PRIVATEJan 12, 2026

Amount Raised

$5 Million

Round Type

Seed

BerkeleyBiotechnologyArtificial IntelligenceMachine LearningPharmaceutical

Investors

Oxford Science Enterprises

Description

Allos AI has emerged from stealth with $5 million in seed financing to commercialize the industry's first 'glass-box' Causal AI platform. This platform aims to reformulate existing complex generics and next-generation medicines to improve patient outcomes. The funding was led by Oxford Science Enterprises. Allos AI seeks to address the formulation gap in the pharmaceutical industry.

Quick answer

Allos AI raised $5 Million in a Seed round, dated January 12, 2026. Investors: Oxford Science Enterprises. Allos AI is based in Berkeley, California, United States.

How much did Allos AI raise?
Allos AI raised $5 Million in a Seed round on January 12, 2026.
Who invested in Allos AI?
Oxford Science Enterprises is named as investors in this round.
What does Allos AI do?
Allos AI uses Causal AI to transform existing complex drugs into more bioavailable, safer, and easier-to-take medicines.
Where is Allos AI based and how big is it?
Allos AI is based in Berkeley, California, United States. Fundz records about 15 employees.
Who are the decision-makers at Allos AI?
Fundz holds 1 contact at Allos AI. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Biotechnology around the same time

Companies in the same sectors as Allos AI that raised within 45 days of this round, from Fundz verified event records.

  • Change Agents Corporation. raised $207K (Debt Financing) on February 25, 2026.
  • Turbine raised $25M (Series B) on February 24, 2026.
  • Peptis raised $7.7M (Series A) on February 21, 2026.
  • Pharmacelera raised $7.1M on February 18, 2026.
  • SYLO raised $320K (Pre-Seed) on February 17, 2026.
  • Stanhope AI raised $8M (Seed) on February 12, 2026.

Who to call at Allos AI, and when

A new round usually means Allos AI is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Allos AI raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Allos AI, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Allos AI. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Allos AI

Location

Berkeley, California, United States

About

Allos AI uses Causal AI to transform existing complex drugs into more bioavailable, safer, and easier-to-take medicines. Founded by a team that brings together an Oxford-trained quantum physicist, applied AI researchers, and industry veterans in complex generics, Allos combines deep scientific expertise with real-world drug development experience. The AI-native company reformulates small-molecule drugs and designs clinical studies grounded in real world evidence from health records that bring molecules to market faster and with greater confidence. Allos collaborates with pharmaceutical companies to modernize legacy assets, unlock stalled programs, and expand access to complex generics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Allos AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Allos AI's next move

See what Strategic adds

Allos AI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.